Sugi Predict

Sugi Predict / Compounds / SCHEMBL5829630

SCHEMBL5829630

SCHEMBL5829630

COCOc1ccc2cc(Br)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ RXFP1 Q9HBX9 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ NCEH1 Q6PIU2 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ CYP2A6 P11509 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KDM1A O60341 1/20 0.43
▸ PRNP P04156 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ STAT1 P42224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29843581 1.00 LMNA (0.45) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL19617126 0.96 CYP2A6 (0.45) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL30198972 0.96 CYP2A6 (0.45) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL31498434 0.83 KDM4E (0.47) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL5829593 0.83 KDM4E (0.47) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL590310 0.81 ALDH1A1 (0.44) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL24150735 0.80 KDM4E (0.49) LMNAL3MBTL1KMT2AMEN1RXFP1
SCHEMBL1961527 0.80 CYP1A2 (0.59) LMNAL3MBTL1KMT2AMEN1MAPT
SCHEMBL29936898 0.80 CYP1A2 (0.59) LMNAL3MBTL1KMT2AMEN1MAPT
SCHEMBL1607926 0.80 NQO1 (0.52) LMNAL3MBTL1KMT2AMEN1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150929-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 UNIV TEXAS (US) 2023-05-18 — — US disclosed
CN-116134015-A Selective acyclic nucleotide activating factor for CAMP sensor EPAC1 得克萨斯州大学系统董事会 2023-05-16 — — CN disclosed
EP-4121411-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-01-25 — — EP disclosed
US-11247905-B2 Synthesis of graphene nanoribbons from monomeric molecular precursors bearing reactive alkyne moieties THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-15 — — US disclosed
WO-2021188728-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-09-23 — — WO disclosed
US-20200055735-A1 SYNTHESIS OF GRAPHENE NANORIBBONS FROM MONOMERIC MOLECULAR PRECURSORS BEARING REACTIVE ALKYNE MOIETIES UNIV CALIFORNIA (US) 2020-02-20 — — US disclosed
US-7045522-B2 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field NEUROSEARCH A/S (DK) 2006-05-16 — — US disclosed
CN-1231483-C 8-azabicyclo [3.2.1] oct-2-ene and-octane derivatives NEUROSEARCH AS (DK) 2005-12-14 — — CN disclosed
US-20040116703-A1 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field NEUROSEARCH A/S 2004-06-17 — — US disclosed
EP-1133494-B1 8-AZABICYCLO 3.2.1]OCT-2-ENE AND -OCTANE DERIVATIVES NEUROSEARCH AS (DK) 2004-02-18 — — EP disclosed
EP-1382605-A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands NEUROSEARCH A/S (DK) 2004-01-21 — — EP disclosed
US-6680328-B2 CHOLINERGIC LIGANDS OF NICOTINIC ACETYL CHOLINE RECEPTORS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, SMOOTH MUSCLE CONTRACTION DISORDERS, ENDOCRINE DISEASES/DISORDERS, NEURODEGENERATION, INFLAMMATION, PAIN, AND DRUG WITHDRAWAL NEUROSEARCH A/S (DK) 2004-01-20 — — US disclosed
US-20020035122-A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives ANIONA APS (DK) 2002-03-21 — — US disclosed
CN-1326456-A 8-azabicyclo [3,.2.1] oct-2-ene and-octane derivatives NEUROSEARCH AS (DK) 2001-12-12 — — CN disclosed
EP-1133494-A1 8-AZABICYCLO 3.2.1]OCT-2-ENE AND -OCTANE DERIVATIVES NEUROSEARCH A/S (DK) 2001-09-19 — — EP disclosed
WO-2000032600-A1 8-AZABICYCLO[3.2.1]OCT-2-ENE AND -OCTANE DERIVATIVES NEUROSEARCH A/S (DK) 2000-06-08 — — WO disclosed
US-5977105-A Compounds ASTRA PHARMAEUTICALS LTD. (GB) 1999-11-02 — — US disclosed
CN-1208403-A Compounds BRITISH ASTRA PHARMACEUTICALS (GB) 1999-02-17 — — CN disclosed
EP-0865431-A2 COMPOUNDS Astra Pharmaceuticals Limited (GB) 1998-09-23 — — EP disclosed
WO-1997020815-A1 COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1997-06-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150929-A1 SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 CREB1, RAPGEF4, ATF4 LMNA 2182/4885L3MBTL1 4018/4885KMT2A 4380/4885
US-20020035122-A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives CHRNA2, CHRNA7, CHRNA10 LMNA 3324/4885L3MBTL1 3585/4885KMT2A 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.